Maverick Capital Ltd. Purchases 165,923 Shares of KKR & Co. Inc. (NYSE:KKR)

Maverick Capital Ltd. increased its position in shares of KKR & Co. Inc. (NYSE:KKR) by 3,646.7% during the second quarter, HoldingsChannel.com reports. The fund owned 170,473 shares of the asset manager’s stock after acquiring an additional 165,923 shares during the period. Maverick Capital Ltd.’s holdings in KKR & Co. Inc. were worth $17,941,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of KKR. MBB Public Markets I LLC increased its holdings in shares of KKR & Co. Inc. by 1,922.2% in the second quarter. MBB Public Markets I LLC now owns 45,520 shares of the asset manager’s stock worth $4,791,000 after purchasing an additional 43,269 shares during the period. Daymark Wealth Partners LLC bought a new stake in KKR & Co. Inc. during the second quarter valued at $821,000. DE Burlo Group Inc. grew its position in KKR & Co. Inc. by 58.5% during the second quarter. DE Burlo Group Inc. now owns 301,500 shares of the asset manager’s stock worth $31,730,000 after buying an additional 111,300 shares in the last quarter. Deerfield Management Company L.P. Series C grew its position in KKR & Co. Inc. by 35.2% during the second quarter. Deerfield Management Company L.P. Series C now owns 6,567 shares of the asset manager’s stock worth $691,000 after buying an additional 1,710 shares in the last quarter. Finally, Engle Capital Management L.P. increased its stake in KKR & Co. Inc. by 15.2% in the 2nd quarter. Engle Capital Management L.P. now owns 190,000 shares of the asset manager’s stock worth $19,996,000 after acquiring an additional 25,000 shares during the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at KKR & Co. Inc.

In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the transaction, the insider now owns 25,260,971 shares in the company, valued at $650,470,003.25. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The stock was bought at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the acquisition, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. The disclosure for this purchase can be found here. 39.34% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on KKR shares. Wells Fargo & Company began coverage on KKR & Co. Inc. in a research report on Thursday, September 12th. They set an “equal weight” rating and a $130.00 price target for the company. StockNews.com upgraded shares of KKR & Co. Inc. to a “sell” rating in a research report on Saturday, September 21st. Argus raised shares of KKR & Co. Inc. to a “strong-buy” rating in a research note on Thursday, August 1st. Oppenheimer raised their price objective on shares of KKR & Co. Inc. from $121.00 to $128.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. Finally, Barclays upped their target price on shares of KKR & Co. Inc. from $114.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $128.27.

KKR & Co. Inc. Price Performance

Shares of KKR & Co. Inc. stock opened at $131.36 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.07 and a quick ratio of 0.07. KKR & Co. Inc. has a one year low of $53.72 and a one year high of $134.85. The business’s 50 day simple moving average is $119.88 and its two-hundred day simple moving average is $108.55. The stock has a market capitalization of $116.57 billion, a P/E ratio of 29.45, a price-to-earnings-growth ratio of 1.11 and a beta of 1.62.

KKR & Co. Inc. (NYSE:KKR) last issued its earnings results on Wednesday, July 31st. The asset manager reported $1.09 EPS for the quarter, topping the consensus estimate of $0.89 by $0.20. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. The company had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same period in the previous year, the firm earned $0.58 earnings per share. Analysts forecast that KKR & Co. Inc. will post 3.99 EPS for the current year.

KKR & Co. Inc. Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 12th were paid a dividend of $0.175 per share. This represents a $0.70 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Monday, August 12th. KKR & Co. Inc.’s dividend payout ratio (DPR) is 15.70%.

About KKR & Co. Inc.

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.